By Brad Sorensen, CFA NASDAQ:EVAX READ THE FULL EVAX RESEARCH REPORT Evaxion (NASDAQ:EVAX) is a clinical stage company that is making AI useful in the current environment by using the technology to develop new cancer-fighting vaccines. The company notes that it has demonstrated that it can identify, through the company’s AI models, novel targets within … Read more
China has unveiled its latest weapon in the battle against cancer – the world’s most powerful vaccine booster, capable of amplifying immune responses to tumours and infections up to 150-fold, according to researchers. The advance promises two potential benefits: enhanced treatments for malignancies such as melanoma and liver cancer and improved vaccine effectiveness against rapidly … Read more
By David Bautz, PhD NASDAQ:IMNN READ THE FULL IMNN RESEARCH REPORT Business Update Protocol in Place for Phase 3 Trial of IMNN-001 in Ovarian Cancer On March 24, 2025, Imunon, Inc. (NASDAQ:IMNN) announced it reached alignment with the U.S. FDA on the protocol for a Phase 3 clinical trial, referred to as OVATION 3, of … Read more
For more than 25 years, Cynthia Hernandez has dedicated her life to providing health care and support to others. Hernandez is currently the department administrator for Allergy and Dermatology at Kaiser Permanente in San Bernardino County, California. But it wasn’t until a close friend’s sister — who was only 30 years old — passed away … Read more
The answer lies in how quickly body size evolves. We found that birds and mammals that reached large sizes more rapidly have reduced cancer prevalence. For example, the common dolphin, Delphinus delphis evolved to reach its large body size—along with most other whales and dolphins (referred to as cetaceans) about three times faster than other … Read more